IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+8.35%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$246M
AUM Growth
+$246M
(+3.6%)
Cap. Flow
-$2.64M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
44.91%
Holding
90
New
21
Increased
16
Reduced
11
Closed
29
Top Buys
| 1 |
Amgen
AMGN
|
$9.21M |
| 2 |
Bausch Health
BHC
|
$7.78M |
| 3 |
Medtronic
MDT
|
$7.41M |
| 4 |
Biogen
BIIB
|
$6.06M |
| 5 |
Viatris
VTRS
|
$5.09M |
Top Sells
| 1 |
Pfizer
PFE
|
$13.4M |
| 2 |
AGN
Allergan plc
AGN
|
$7.44M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$6.22M |
| 4 |
Puma Biotechnology
PBYI
|
$5.9M |
| 5 |
Zimmer Biomet
ZBH
|
$5.88M |
Sector Composition
| 1 | Healthcare | 87.35% |
| 2 | Technology | 0.4% |
| 3 | Financials | 0% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ultragenyx Pharmaceutical
RARE
$2.89B
| $20.5M | 6.46% | 200,000 +25,000 | +14% | +$2.56M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $17.4M | 5.48% | 150,000 +40,000 | +36% | +$4.63M |
|
3
Esperion Therapeutics
ESPR
$448M
| $12.3M | 3.87% | 150,000 -50,000 | -25% | -$4.09M |
|
4
Gilead Sciences
GILD
$140B
| $11.7M | 3.69% | 100,000 | – | – |
|
|
5
Amgen
AMGN
$155B
| $9.21M | 2.91% | +60,000 | New | +$9.21M |
|
|
ESRX
6
DELISTED
Express Scripts Holding Company
ESRX
| $8.89M | 2.81% | 100,000 +40,000 | +67% | +$3.56M |
|
7
Elevance Health
ELV
$71.8B
| $8.21M | 2.59% | 50,000 +30,000 | +150% | +$4.92M |
|
|
8
Bausch Health
BHC
$2.74B
| $7.78M | 2.45% | +35,000 | New | +$7.78M |
|
|
9
Medtronic
MDT
$119B
| $7.41M | 2.34% | +100,000 | New | +$7.41M |
|
|
STJ
10
DELISTED
St Jude Medical
STJ
| $7.31M | 2.31% | 100,000 +25,000 | +33% | +$1.83M |
|
|
AXDX
11
DELISTED
Accelerate Diagnostics
AXDX
| $6.97M | 2.2% | 270,000 +20,000 | +8% | +$516K |
|
|
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.95M | 2.19% | 200,000 | – | – |
|
|
13
Pfizer
PFE
$141B
| $6.71M | 2.12% | 200,000 -400,000 | -67% | -$13.4M |
|
14
Cigna
CI
$80.3B
| $6.48M | 2.04% | 40,000 +10,000 | +33% | +$1.62M |
|
|
15
Biogen
BIIB
$19.4B
| $6.06M | 1.91% | +15,000 | New | +$6.06M |
|
|
IPXL
16
DELISTED
Impax Laboratories, Inc.
IPXL
| $5.74M | 1.81% | 125,000 +50,000 | +67% | +$2.3M |
|
|
GWPH
17
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.53M | 1.74% | 45,000 -5,000 | -10% | -$614K |
|
|
18
Viatris
VTRS
$12.3B
| $5.09M | 1.61% | +75,000 | New | +$5.09M |
|
19
Edwards Lifesciences
EW
$47.8B
| $4.99M | 1.57% | +35,000 | New | +$4.99M |
|
|
NVDQ
20
DELISTED
Novadaq Technologies Inc.
NVDQ
| $4.84M | 1.53% | 400,000 +200,000 | +100% | +$2.42M |
|
|
XLRN
21
DELISTED
Acceleron Pharma Inc.
XLRN
| $4.75M | 1.5% | 150,000 -25,000 | -14% | -$791K |
|
22
Supernus Pharmaceuticals
SUPN
$2.53B
| $4.5M | 1.42% | 265,000 -235,000 | -47% | -$3.99M |
|
23
Teva Pharmaceuticals
TEVA
$21.1B
| $4.43M | 1.4% | +75,000 | New | +$4.43M |
|
|
IPCM
24
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $4.15M | 1.31% | 75,000 +40,000 | +114% | +$2.22M |
|
|
TRNX
25
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $3.75M | 1.18% | 150,000 | – | – |
|